Mycophenolate mofetil-based salvage as acute GVHD prophylaxis after early discontinuation of tacrolimus and/or sirolimus

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2015-02, Vol.50 (2), p.307-309
Hauptverfasser:	Ali, H, Palmer, J, Eroglu, Z, Stiller, T, Thomas, S H, Khaled, S, Shayani, S, Parker, P, Forman, S J, Nakamura, R
Format:	Artikel
Sprache:	eng
Schlagworte:	692/700/459 Acute Disease Adult Aged Allografts Bone marrow Cell Biology Complications and side effects Disease-Free Survival Drug therapy Female Graft vs Host Disease - mortality Graft vs Host Disease - prevention & control Graft vs. host disease Graft-versus-host reaction Health aspects Hematologic Neoplasms - mortality Hematologic Neoplasms - therapy Hematology Hematopoietic Stem Cell Transplantation Humans Immunosuppressive Agents - administration & dosage Internal Medicine letter-to-the-editor Male Medicine Medicine & Public Health Middle Aged Mycophenolate mofetil Mycophenolic acid Mycophenolic Acid - administration & dosage Mycophenolic Acid - analogs & derivatives Prophylaxis Public Health Rapamycin Retrospective Studies Risk factors Sirolimus - administration & dosage Stem cell transplantation Stem Cells Survival Rate Tacrolimus Tacrolimus - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!